Sublingual Semaglutide
What is it?
Semaglutide is the active ingredient in commercially available products such as Ozempic, Rybelsus, and Wegovy. Semaglutide is a medication used in the treatment of type 2 diabetes and obesity. Sublingual semaglutide is administered in a liquid under the tongue. This is especially beneficial for semaglutide, as it ensures more consistent and reliable drug delivery, which is critical for maintaining the therapeutic efficacy of the medication.
What to expect?
Treatment with semaglutide can take weeks to see effectiveness. The patient must slowly titrate the dose until a maintenance dose is reached. Semaglutide can also cause various side effects such as nausea, headache, diarrhea, constipation, stomach pain, upset stomach, and vomiting.
What now?
- Insurance is not billed for any compounded medications.
- In order to fill compounded sublingual semaglutide, we need a prescription from your healthcare provider.
- Provider can call in the prescription to 501-225-2222
- Fax the following form to 501-225-8683 (click below)
- Electronically prescribe
No compounded medication is reviewed by FDA for safety or efficacy. SubMagna™ HMW is a trademark of Kingdom Licensing.The FDA does not review any compounded medication from any pharmacy for safety or efficacy. RYBELSUS®, WEGOVY®, and OZEMPIC® are registered trademarks of Novo Nordisk A/S. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute forconventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.